1,768
Views
3
CrossRef citations to date
0
Altmetric
Immune Thrombocytopenia

Tolerability and safety of the intravenous immunoglobulin octagam® 10% in patients with immune thrombocytopenia: a post-authorisation safety analysis of two non-interventional phase IV trials

ORCID Icon, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (3)